TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in TFF Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q1 2024
- Shares held
- 643.6K
- +292.7K (+83.4%) vs. Q1 2024
- Total value
- $1.07M
- −$1.06M (−49.7%) vs. Q1 2024
- New holders
- 4
- 5 more added
- Sold out
- 2
- 7 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TFFP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 3 | $0 |
| Q4 2024 | 4 | $196 |
| Q3 2024 | 23 | $1.48M |
| Q2 2024 | 21 | $1.07M |
| Q1 2024 | 19 | $2.12M |
| Q4 2023 | 23 | $2.45M |
| Q3 2023 | 41 | $4.04M |
| Q2 2023 | 33 | $3.02M |
| Q1 2023 | 36 | $4.80M |
| Q4 2022 | 41 | $7.52M |
| Q3 2022 | 45 | $17.2M |
| Q2 2022 | 45 | $23.7M |
| Q1 2022 | 43 | $27.1M |
| Q4 2021 | 51 | $41.1M |
| Q3 2021 | 54 | $45.1M |
| Q2 2021 | 60 | $54.5M |
| Q1 2021 | 63 | $96.1M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding TFF Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 156 | $0 | 0.00% | −331−68.0% | Reduced |
| Bank of America Corp | 23 | $38 | 0.00% | −12−34.3% | Reduced |
| Morgan Stanley | 32 | $53 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 40 | $66 | 0.00% | 00.0% | Unchanged |
| HM Payson & Co | 60 | $100 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 61 | $101 | 0.00% | −17−21.8% | Reduced |
| Raleigh Capital Management Inc. | 91 | $151 | 0.00% | +91 | New |
| Gen-Wealth Partners Inc | 100 | $166 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 735 | $1.22K | 0.00% | −392−34.8% | Reduced |
| ORG Partners LLC | 740 | $1.32K | 0.00% | +740 | New |
| University of Texas/Texas Am Investment Managment Co | 882 | $1.46K | 0.00% | −882−50.0% | Reduced |
| Tower Research Capital LLC (TRC) | 4,932 | $8.19K | 0.00% | +4,430+882.5% | Added |
| BlackRock Inc. | 7,186 | $11.9K | 0.00% | −613−7.9% | Reduced |
| Nwam LLC | 10,240 | $17.0K | 0.00% | +10,240 | New |
| Vanguard Group Inc | 12,136 | $20.1K | 0.00% | −22,607−65.1% | Reduced |
| Renaissance Technologies LLC | 14,777 | $24.5K | 0.00% | +1,579+12.0% | Added |
| Geode Capital Management, LLC | 21,798 | $36.2K | 0.00% | +4,455+25.7% | Added |
| DRW Securities, LLC | 40,000 | $66.4K | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 50,491 | $83.8K | 0.02% | +11,266+28.7% | Added |
| Armistice Capital, LLC | 185,695 | $308.3K | 0.01% | +185,695 | New |
| Carlson Capital L P | 293,460 | $487.1K | 0.08% | +99,500+51.3% | Added |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −434−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |